Group of popular arthritis drugs may pose risk of heart problems, blood clots, cancer and death, says Health Canada
Update: On November 1, 2022, Health Canada published multiple safety alerts to notify the general public and medical community about new warnings required for the Canadian labels for all Janus Kinase Inhibitors concerning risks of serious heart-related problems, fatal blood clots and cancer,…Continue reading the post titled Group of popular arthritis drugs may pose risk of heart problems, blood clots, cancer and death, says Health Canada
Federal Court grants injunctive relief against interfering law firm – Moushoom v Canada (Attorney General)
In August 2022, the Federal Court released its decision in Moushoom v Canada (Attorney General), 2022 FC 1212 (“Moushoom”), granting the Plaintiffs’ motion for an interlocutory order that no legal professionals other than class counsel, the Plaintiff Assembly of First Nations, or the Court-a…Continue reading the post titled Federal Court grants injunctive relief against interfering law firm – Moushoom v Canada (Attorney General)
Beyond “functional disclosure” – Ontario Court of Appeal applies the rule from Handley Estate in CHU de Québec-Université Laval v. Tree of Knowledge International Corp.
In multi-party litigation, situations may arise where one or more defendants are inclined to settle a plaintiff’s claims while others are not. In these circumstances, the settling defendant may execute a settlement agreement with the plaintiff called a Pierringer agreement. Essentially, Pier…Continue reading the post titled Beyond “functional disclosure” – Ontario Court of Appeal applies the rule from Handley Estate in CHU de Québec-Université Laval v. Tree of Knowledge International Corp.
Johnson & Johnson stopping all sales of talcum-based baby powder
On August 11, 2022, global pharmaceutical and consumer products giant Johnson & Johnson (“J&J”) announced that it would stop all sales of its talc-based baby powder products in 2023. The announcement is noteworthy news for tens of thousands of women who are bringing lawsuits agains…Continue reading the post titled Johnson & Johnson stopping all sales of talcum-based baby powder
Arthritis medication Xeljanz linked to risk of heart attack and cancer
Pfizer’s Xeljanz and Xeljanz XR (tofacitinib), a popular drug used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis, has been linked to an increased risk of serious heart problems, cancer, and death, especially in older patients – the largest demographic among…Continue reading the post titled Arthritis medication Xeljanz linked to risk of heart attack and cancer
Surgical stapler malfunctions can result in serious injuries
Surgical staplers are medical devices often used to close wounds during surgery, both internally and externally. Surgical staplers are commonly used for gastrointestinal surgeries, including bowel resections, colorectal cancer surgeries, bariatric surgeries, and other conditions. When a surg…Continue reading the post titled Surgical stapler malfunctions can result in serious injuries
Intervenor beware! – Brewers Retail v. Campbell
In Brewers Retail v Campbell, 2022 ONSC 2795, Justice Morgan dealt with costs in “procedurally unusual circumstances”: the Financial Services Regulatory Authority (“FSRA”), Ontario’s pension regulator, was granted intervenor status to oppose a consent motion for certification for settlement …Continue reading the post titled Intervenor beware! – Brewers Retail v. Campbell
Not all privacy is worthy of protection: Stewart v Demme at the Divisional Court
In Stewart v. Demme, 2022 ONSC 1790, the Divisional Court set aside an order certifying a privacy class action against a hospital and its former employee, Catharina Demme, who was then a nurse. The decision, written for a unanimous panel by Justice Sachs, marks another case in which the Di…Continue reading the post titled Not all privacy is worthy of protection: Stewart v Demme at the Divisional Court
Yes, no or maybe so? Are evidentiary requirements on OSA leave motions broadening?
In O’Brien v. Maxar Technologies Inc., Justice Akbarali declined to grant the plaintiffs’ motion for leave to proceed with claims under section 138.3(1) of the Ontario Securities Act (“OSA”), concluding that there was no reasonable possibility that the action would be resolved in favour of t…Continue reading the post titled Yes, no or maybe so? Are evidentiary requirements on OSA leave motions broadening?
Getting it right in Ontario courts’ treatment of honoraria – Doucet and Redublo
In the event of a successful monetary settlement in a class proceeding, courts may order that additional compensation, in the form of a payment called an honorarium, be paid to a representative plaintiff who has meaningfully contributed to advancing litigation on behalf of the class. Honorar…Continue reading the post titled Getting it right in Ontario courts’ treatment of honoraria – Doucet and Redublo
Receive Blog Posts
By subscribing to our blog, you will receive an email when a new post is added. You can unsubscribe at any time by sending an email to us at [email protected] with the word “unsubscribe” in the subject line.